Skip to content
ChickenStockChickenStock
ResearchFilings

AI English summary of an SEC filing — figures as filed

Nordson logoNordson NDSN

Nordson said fourth-quarter sales for October 31, 2025 were $752 million, up 1% from prior-year fourth-quarter sales of $744 million, and diluted earnings per share were $2.69, with adjusted diluted earnings per share of $3.03.

8-KResults of Operations and Financial ConditionFiled Period of report Summary published (UTC)

Key points

AI summary
  1. Nordson said fourth-quarter sales for October 31, 2025 were $752 million, up 1% from prior-year fourth-quarter sales of $744 million, and diluted earnings per share were $2.69, with adjusted diluted earnings per share of $3.03.

  2. The company said full-year 2025 sales were $2.8 billion, up 4% from the prior year. Full-year free cash flow was $661 million, representing a conversion rate of 136% of net income.

  3. Nordson said Industrial Precision Solutions sales in Q4 were $362 million, down 2%, Medical and Fluid Solutions were $220 million, up 10%, and Advanced Technology Solutions were $171 million, down 4%.

  4. The company said it expects 2026 sales in the range of $2,830 million to $2,950 million and adjusted diluted earnings per share in the range of $10.80 to $11.50. For Q1 of fiscal 2026, it expects sales in the range of $630 million to $670 million.

Summary

AI-written

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

Q4 Sales $752 million, Adjusted Diluted Earnings Per Share $3.03

Nordson said fourth-quarter sales for October 31, 2025 were $752 million, up 1% from prior-year fourth-quarter sales of $744 million, and diluted earnings per share were $2.69, with adjusted diluted earnings per share of $3.03.

Source · Based on the filing body and exhibits

Full-Year Sales $2.8 billion, Free Cash Flow $661 million

The company said full-year 2025 sales were $2.8 billion, up 4% from the prior year. Full-year free cash flow was $661 million, representing a conversion rate of 136% of net income.

Source · Based on the filing body and exhibits

Q4 Segment Sales

Nordson said Industrial Precision Solutions sales in Q4 were $362 million, down 2%, Medical and Fluid Solutions were $220 million, up 10%, and Advanced Technology Solutions were $171 million, down 4%.

Source · Based on the filing body and exhibits

Fiscal 2026 Sales and Adjusted Earnings Outlook

The company said it expects 2026 sales in the range of $2,830 million to $2,950 million and adjusted diluted earnings per share in the range of $10.80 to $11.50. For Q1 of fiscal 2026, it expects sales in the range of $630 million to $670 million.

Source · Based on the filing body and exhibits

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.

Source: SEC EDGAR (U.S. Securities and Exchange Commission). Item captions are the SEC's. The summary is for reference only and is not investment advice.